Tilos Therapeutics
United StatesEntry
2016
Hold
3yr
Exit
2019
Who owns Tilos Therapeutics?
Tilos Therapeutics is an American Biotech company, now owned by Merck, which acquired it in 2019 from Boehringer Ingelheim Venture Fund.
Hand-verified · updated 2026-07-07
Open JSON · CC-BY
Exit Type
Trade Sale
Buyer
Merck
Exit Year
2019
More from Boehringer Ingelheim Venture Fund
Other portfolio companies in the same fund.
Germany
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Tilos Therapeutics?
Tilos Therapeutics is now owned by Merck, which acquired it in 2019 from Boehringer Ingelheim Venture Fund.
When did Merck acquire Tilos Therapeutics?
Merck acquired Tilos Therapeutics in 2019, buying from Boehringer Ingelheim Venture Fund.
Who did Tilos Therapeutics sell to?
Boehringer Ingelheim Venture Fund sold Tilos Therapeutics to Merck in 2019 (Trade Sale).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue